Improved long term prognosis after myocardial infarction 1984-1991

European Heart Journal

Volumn 19, Issue 10, 1998, Pages 1512-1517

  Abrahamsson, P ^a   Dellborg, M ^a   Rosengren, A ^a   Wilhelmsen, L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Myocardial infarction; Prognosis; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE;

AGE; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL TIME; SWEDEN;

AGED; AGED, 80 AND OVER; CORONARY CARE UNITS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALS, COMMUNITY; HUMANS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; URBAN POPULATION;

EID: 0032188761     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1026     Document Type: Article

References (28)

1. [1] The MIAMI trial research group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 1985; 6: 199-211.
2. [2] Salathia KS, Barber JM, Mcllmoyle EL et al. Very early intervention with Metoprolol in suspected acute myocardial infarction. Eur Heart J 1985; 6: 190-8.
3. [3] The ISIS-1 collaborative group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986; ii: 57-66.
4. [4] Hjalmarson Å, Elmfeldt D, Herlitz J et al. Effect on mortality of Metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet 1981; ii: 823-7.
5. [5] GISSI. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987; ii: 871-4.
6. [6] The ISIS-2 collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349-60.
7. [7] Wilcox RG, von der Lippe G, Olsson CG, Jansen G, Skene AM, Hampton JR, for the ASSET study group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian study of early thrombolysis (ASSET). Lancet 1988; ii: 525-30.
8. [8] Van de Werf F, Arnold AER. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ 1988; 297: 1374-9.
9. [9] Wilcox RG, von der Lippe G, Olsson CG et al. Effects of alteplase in acute myocardial infarction: 6 month result from the ASSET study. Lancet 1990; 335: 1175-8.
10. [10] Armstrong PW, Baigrie RS, Daly PA et al. Tissue Plasminogen Activator: Toronto (TPAT) placebo-controlled randomised trial in acute myocardial infarction. J Am Coll Cardiol 1989; 13: 1469-76.
11. [11] Fibrinolytic Therapy Trialists' (FTT) Collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
12. [12] Dellborg M, Eriksson P, Riha M, Swedberg K. Declining hospital mortality in acute myocardial infarction. Eur Heart J 1994; 15: 5-9.
13. [13] Naylor CD, Chen E. Population-wide mortality trends among patients hospitalised for acute myocardial infarction: The Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994; 24: 1431-8.
14. [14] Gillum RF. Trends in acute myocardial infarction and coronary heart disease death in the United States. J Am Coll Cardiol 1993; 23: 1273-7.
15. [15] Gheorghiade M, Ruzumma P, Borzak S, Havstad S, Ali A, Goldstein S. Decline in the rate of hospital mortality from acute myocardial infarction: Impact of changing management strategies. Am Heart J 1996; 131: 250-6.
16. [16] Wilkinson P, Laji K, Ranjadayalan K, Parsons L, Timmis AD. Acute myocardial infarction in women: survival analysis in first six months. BMJ 1994; 309: 566-9.
17. [17] McGovern PG, Pancow JS, Shahar E et al. Recent trends in acute coronary heart disease. N Engl J Med 1996; 334: 884-90.
18. [18] Furberg CD. Secondary prevention trials after myocardial infarction. Am J Cardiol 1987; 60: 28-32.
19. [19] Abrahamsson P, Dellborg M, Swedberg K. Effects of active treatment of acute myocardial infarction on mortality and recovery in very elderly patients. Cardiol Elderly 1996; 4: 89-93.
20. [20] Torp-Pedersen C, Hildebrandt P, Kober L et al. Improving long term survival of patients with acute myocardial infarction from 1977-1988 in a region of Denmark. Eur Heart J 1995; 16: 14-20.
21. [21] De Vreede JJ, Gorgels AP, Verstraaten GM, Vermeer F, Dassen WR, Hein JJ. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 1991; 18: 698-706.
22. [22] Herlitz J, Karlsson BW, Hjalmarson Å. Predictors of death and ventricular fibrillation in acute myocardial infarction. Cor Art Dis 1992; 3: 651-8.
23. [23] Greenland P, Reicher-Reiss H, Goldbourt U, Behar S, and the Israeli SPRINT investigators. In hospital and one year mortality in 1524 women after myocardial infarction: comparison with 4315 men. Circulation 1991; 83: 484-91.
24. [24] Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary artery disease: An investigation in differences in outcome between sexes according to initial coronary disease presentation. Circulation 1993; 88: 2548-55.
25. [25] Tofler GH, Stone PH, Muller JE et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987; 9: 473-82.
26. [26] Lincoff AM, Califf RM, Ellis SG et al. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? J Am Coll Cardiol 1993; 22: 1780-7.
27. [27] Dittrich H, Giplin E, Nicod P, Cali G, Henning H, Ross J. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988; 62: 1-7.
28. [28] Robinson K, Conroy RM, Mulcahy R, Hickey N. Risk factors and in hospital course of first episode of myocardial infarction or acute coronary insufficiency in women. J Am Coll Cardiol 1988; 11: 932-6.